Article Text
PDF
Statistics from Altmetric.com
Creativity is the ability to illustrate what is outside the box from within the box. Oscar Wilde.
To explore whether creativity in people with Parkinson’s disease might be enhanced by dopamine replacement therapy and especially by dopamine agonists, we asked six people with Parkinson’s disease (mean age 70±5 years, evolution over 5.5±2.0 years) visiting our clinic to draw on a blank sheet of paper (for 2 min) the first thing that came to mind. None …
Footnotes
Contributors The author conceived, organised and executed the study.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Provenance and peer review Not commissioned. Externally peer reviewed by Simon Lewis, Sydney, Australia.
Linked Articles
- Editors’ commentary
Read the full text or download the PDF:
Other content recommended for you
- Parkinson disease and impulse control disorders: a review of clinical features, pathophysiology and management
- Clinical features of dopamine agonist withdrawal syndrome in a movement disorders clinic
- Incident impulse control disorder symptoms and dopamine transporter imaging in Parkinson disease
- Extrastriatal dopaminergic changes in Parkinson’s disease patients with impulse control disorders
- Clinical-genetic model predicts incident impulse control disorders in Parkinson's disease
- Behavioural and trait changes in parkinsonian patients with impulse control disorder after switching from dopamine agonist to levodopa therapy: results of REIN-PD trial
- Dopamine dysregulation syndrome in Parkinson's disease: from clinical and neuropsychological characterisation to management and long-term outcome
- Impulse control disorder in patients with Parkinson's disease under dopamine agonist therapy: a multicentre study
- Impulse control disorders in Parkinson's disease: decreased striatal dopamine transporter levels
- Sleep and REM sleep behaviour disorder in Parkinson’s disease with impulse control disorder